Peter is currently a Non-Executive Director of Mereo BioPharma Group plc, a company listed on the London AIM and NASDAQ Exchanges, where he is Chair of the Remuneration Committee as well as serving on the Nomination and R&D Committees.
Peter has over three decades of experience in the biotech and pharmaceutical industry, which included a 23-year career at GlaxoSmithKline, where he held numerous senior operational and strategic roles. He also served as the Representative Executive Officer and Chief Executive Officer of Sosei Group Corporation, a Tokyo listed biotech company, and Chief Executive Officer of Syngene International, which he successfully took public on the Mumbai Exchanges in 2015.
He also serves as a Non-Executive Director for MiNA Therapeutics and Apterna.
Peter has a BSc Combined (Honours) in Physiology/Zoology from Sheffield University.
Member of the Audit Committee
Member of the Science & Policy Committee